Document is current
Any future updates will be listed below
-
Authors
Stahl, Anna
Østergaard, Lauge
Havers-Borgersen, Eva
Strange, Jarl Emanuel
Voldstedlund, Marianne
Køber, Lars
Fosbøl, Emil Loldrup
- License Information
-
More Information
Article History
Received: 27 June 2023
Accepted: 6 October 2023
First Online: 24 October 2023
Declarations
:
: In Denmark, by law, register-based studies conducted with the sole purpose of research and statistics do not require ethical approval or informed consent. This study is however approved by the data responsible institute in accordance with the General Data Protection Regulation (GDPR) (Capital Region of Denmark – Approval number: P-2019–191).
: Dr. Østergaard reports an independent research grant from the Novo Nordisk Foundation for the study of mitral valve regurgitation. Dr. Voldstedlund reports a Grant for Statens Serum Institut as an institution on <i>United4survaeillance</i> – EU commission: <i>Improvement of national lab-based surveillance.</i> Dr. Køber reports Speaker’s fee from <i>AstraZeneca, Bayer, Boehringer, Novartis and Novo.</i> Dr. Fosbøl reports an independent research grant for valvular heart disease from <i>Novo Nordisk Foundation</i> and <i>Danish Heart Association.</i> None above is related to the current study. All other authors declare no conflicts of interest.
